MENU
YARW Yarrow Bioscience Inc Forecast, Technical & Fundamental Analysis
Yarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases... Show more
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I. Advisor
published Earnings
YARW is expected to report earnings to rise 694.39% to -1700 cents per share on November 05
Q3'26
Est.
$-17.00
Q2'26
Missed
by $1.92
The last earnings report on August 13 showed earnings per share of -214 cents, missing the estimate of -21 cents. With 52.95K shares outstanding, the current market capitalization sits at 202.54M.
Interesting Articles
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TPHD | 42.28 | N/A | N/A |
| Timothy Plan High Dividend Stock ETF (TPHD) | |||
| OBND | 24.68 | -0.04 | -0.16% |
| State Street Loomis Sayles Opportunistic Bond ETF (OBND) | |||
| UPGD | 81.65 | -0.13 | -0.16% |
| Invesco Bloomberg Analyst Rating Improvers ETF (UPGD) | |||
| FB | 45.80 | -0.13 | -0.29% |
| ProShares S&P 500 Dynamic Buffer ETF (FB) | |||
| BST | 48.82 | -1.27 | -2.54% |
| BlackRock Science and Technology Trust | |||
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
251 Little Falls Drive
Phone
N/A
Employees
4
Web
https://www.yarrowbioscience.com